Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia

Comment

John E Cornell et al. Ann Intern Med. 2015.

. 2015 Aug 4;163(3):242-3.

doi: 10.7326/L15-5118-3.

No abstract available

Comment on

Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia: A Systematic Review and Meta-analysis.
Navarese EP, Kolodziejczak M, Schulze V, Gurbel PA, Tantry U, Lin Y, Brockmeyer M, Kandzari DE, Kubica JM, D'Agostino RB Sr, Kubica J, Volpe M, Agewall S, Kereiakes DJ, Kelm M. Navarese EP, et al. Ann Intern Med. 2015 Jul 7;163(1):40-51. doi: 10.7326/M14-2957. Ann Intern Med. 2015. PMID: 25915661
Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia.
Liakos A, Athanasiadou E, Mainou M, Bekiari E, Haidich AB, Rizos EC, Tsapas A. Liakos A, et al. Ann Intern Med. 2015 Aug 4;163(3):241. doi: 10.7326/L15-5118. Ann Intern Med. 2015. PMID: 26237757 No abstract available.
Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia.
Battaggia A, Donzelli A, Font M. Battaggia A, et al. Ann Intern Med. 2015 Aug 4;163(3):241-2. doi: 10.7326/L15-5118-2. Ann Intern Med. 2015. PMID: 26237758 No abstract available.